KRAS and non-small cell lung carcinoma: To provide new research directions for the treatment of NSCLC, it is important to understand the mechanism and regulatory network of ferroptosis, the role of NSCLC‐related regulatory genes (such as KRAS, TP53, EGFR, etc.)in ferroptosis, and the relationship between ferroptosis and chemotherapy, radiotherapy, and immunotherapy.